SnagRx vs Vaylen: Compounded GLP-1 Plans Compared
SnagRx vs Vaylen is a choice between two cash-pay telehealth sellers of compounded GLP-1s. Early verdict: SnagRx is the lower annualized entry price for compounded semaglutide if you accept a 12-month plan and compounded drug sourcing; Vaylen offers more formats including oral semaglutide and availability in all 50 states but requires prepaying a year.
See SnagRx semaglutide from $69/mo
How pricing and billing compare
Both providers publish annualized low rates on 12-month plans and both sell compounded medications that are not FDA-approved finished products. SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on a 12-month plan, with month-to-month pricing higher at $99 and $149. Vaylen lists semaglutide injections from $83.25/month, oral semaglutide at $99/month, and tirzepatide at $149/month, all as prepaid 12-month plan rates billed upfront.
Three distinctive differences to judge
1. Price level and price lock
SnagRx positions the annual plan as the bottom of market pricing for compounded GLP-1s, with a stated rate lock meaning the price does not rise as your dose escalates or at renewal. Vaylen also states the same price every month at every dosage level for its prepaid plans, but its headline semaglutide rate is higher at $83.25/month on the 12-month program. Both emphasize flat pricing during titration, but SnagRx highlights the lower $69 figure on the annual plan.
Explore Vaylen plans from $83.25/mo
2. Medication formats and molecule options
Vaylen supports three formats: weekly semaglutide injections, daily oral semaglutide tablets, and weekly tirzepatide, all offered as compounded products. SnagRx focuses on compounded semaglutide and tirzepatide injections only. If a needle-free oral option matters, Vaylen includes it; SnagRx does not list an oral format in the supplied evidence.
3. Payment timing and refund policy
Vaylen requires prepaying a full year before clinician review but states a full refund if the clinician declines to prescribe for that billing cycle. SnagRx uses a more typical assessment-first flow where a clinician review occurs after intake and SnagRx states a full refund if the prescription is declined. Vaylen explicitly notes you pay before any clinician review; SnagRx indicates clinician review typically within five hours and always within 24.
4. Availability and clinician coverage
Vaylen states licensed clinicians in all 50 states. SnagRx names its clinician network as OpenLoop Health covering 48 states in the supplied evidence. Both claim LegitScript certification and clinician oversight, with SnagRx naming its four US 503A partner pharmacies and Vaylen stating fulfillment by licensed U.S. pharmacies.
Comparison table at a glance
| Criteria | SnagRx | Vaylen |
|---|---|---|
| Semaglutide 12-month rate | $69/mo | $83.25/mo |
| Tirzepatide 12-month rate | $119/mo | $149/mo |
| Oral semaglutide | No oral format listed | $99/mo (12-month) |
| Payment timing | Clinician review typically within 5 hours after intake | Prepay full year before clinician review; refund if declined |
| Clinician coverage | OpenLoop Health, 48 states stated | Licensed clinicians in all 50 states |
| Shipping | Next-day UPS/FedEx, temperature-controlled | Free discreet shipping in 1 to 3 business days |
| Compounded medication note | Compounded, not FDA-approved finished products | Compounded, not FDA-approved finished products |
Clinical turnaround, shipping, and customer protections
SnagRx states OpenLoop clinicians typically review intake within five hours and orders ship next-day in temperature-controlled packaging, with a full refund if the prescription is declined and a six-month weight-loss guarantee with terms. Vaylen states clinician review within 24 hours, free discreet shipping in 1 to 3 business days, and a published full refund if the clinician declines to prescribe for that billing cycle. Both caution that compounded medications are not FDA-approved finished products.
Check SnagRx shipping and clinician details
Pros and cons summarized
SnagRx pros in the supplied evidence: lower annualized semaglutide and tirzepatide rates on a 12-month plan, price lock at every dose, named US 503A pharmacies, clinician review speed, and stated refund and guarantee policies. Cons: the low rates require a 12-month commitment and all offerings are compounded medications, not branded FDA-approved finished products. Vaylen pros: supports injections and a needle-free oral tablet, publishes a full-refund policy if declined, clinician coverage in all 50 states, and bundled clinician review with no consultation fee. Cons: you prepay a full year before clinician review, and the oral tablet costs more than the injectable equivalent on the supplied pricing.
View Vaylen format and refund terms
Conclusion: SnagRx vs Vaylen
In a direct SnagRx vs Vaylen comparison, SnagRx offers the lower advertised 12-month semaglutide rate and a price lock at every dose, while Vaylen offers more product formats including an oral option and clinician access in all 50 states but requires prepaying a year. Both use compounded medications that are not FDA-approved finished products; both state refund protections if a clinician declines to prescribe.
Choose SnagRx if…
You want the lowest annualized compounded semaglutide or tirzepatide rate in the supplied evidence, a price locked at every dose, named US 503A pharmacies, and faster clinician review after intake.
Choose Vaylen if…
You need a needle-free oral semaglutide option or clinician coverage in all 50 states and you accept prepaying a full year with a stated refund if the clinician declines.